A detailed history of Herold Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Herold Advisors, Inc. holds 12,240 shares of ABT stock, worth $1.46 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
12,240
Previous 12,280 0.33%
Holding current value
$1.46 Million
Previous $1.28 Million 9.33%
% of portfolio
0.31%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $4,002 - $4,725
-40 Reduced 0.33%
12,240 $1.4 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $780,001 - $861,477
-7,122 Reduced 36.71%
12,280 $1.4 Million
Q4 2023

Feb 02, 2024

SELL
$90.19 - $110.4 $94,519 - $115,699
-1,048 Reduced 5.12%
19,402 $2.14 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $770,162 - $924,066
8,062 Added 65.08%
20,450 $1.98 Million
Q2 2023

Jul 14, 2023

SELL
$100.78 - $112.29 $30,234 - $33,687
-300 Reduced 2.36%
12,388 $1.35 Million
Q1 2023

Apr 19, 2023

SELL
$96.86 - $114.01 $412,042 - $484,998
-4,254 Reduced 25.11%
12,688 $1.28 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $95,060 - $111,520
1,000 Added 6.27%
16,942 $1.86 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $47,799 - $55,342
-494 Reduced 3.01%
15,942 $1.54 Million
Q2 2022

Jul 15, 2022

BUY
$102.07 - $123.37 $33,887 - $40,958
332 Added 2.06%
16,436 $1.79 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $163,618 - $199,522
1,435 Added 9.78%
16,104 $1.91 Million
Q4 2021

Jan 20, 2022

BUY
$115.53 - $141.46 $57,765 - $70,730
500 Added 3.53%
14,669 $2.06 Million
Q3 2021

Nov 03, 2021

BUY
$116.66 - $129.06 $1.65 Million - $1.83 Million
14,169 New
14,169 $1.67 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Herold Advisors, Inc. Portfolio

Follow Herold Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.